Guggenheim analyst Seamus Fernandez initiated coverage of CymaBay with a Buy rating and $20 price target.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CBAY:
- CymaBay reports Q2 EPS (1c), consensus (20c)
- CymaBay Reports Second Quarter and Six Months Ended June 30, 2023 Financial Results and Provides Corporate Update
- CymaBay initiates Phase 3 study of Seladelpar
- William Blair biotech analysts to hold an analyst/industry conference call
- Is CBAY a Buy, Before Earnings?